Anxo Pharmaceutical Co., Ltd. (ANXO) will exhibit at CPhI Japan 2019 from March 18-20. Come check out ANXO’s high-level technique platforms and outstanding drug product lines in Tokyo!

CPhI Japan is a leading pharmaceutical networking event in Asian pacific. It is a trade fair that involves business from ingredients, contract services and biopharma through to technology, packaging and machinery, and with 550+ exhibitors and 200+ seminars & conferences, CPhI Japan is expected to bring almost 30,000 pharma industry professionals from around 60 countries together.

ANXO attached great importance in Japan market which is the world’s 3rd largest pharma industry, worth of 108.2 billion dollars; it represents over 11% of the global drug market with a compound annual growth rate of 3.9% between 2013 and 2023. Exhibiting at CPhI Japan 2019 also reflects ANXO’s strong conviction to go forward from Taiwan to greater Asian markets. Recognizing collaboration is one of pharma trends nowadays, ANXO will promote its excellent controlled/extended-release products into multiple markets through seeking engagement in various regional and global collaborations. 

This time at CPhI Japan, ANXO will typically focus on promoting its self-developed special dosage development platforms and controlled/extended-release products, on which ANXO has continuously devoted time and effort to. With these special technique platforms, ANXO has successfully demonstrated serial products spanning major therapeutic fields, and all, especially products of CNS and nephrology, are believed to draw high attention in the fair.

ANXO cordially invites you to CPhI Japan 2019 and visit us!

‧Date: March 18-20, 2019

‧Venue: Big Sight Exhibition Center, Tokyo, JAPAN

‧Hall/Booth: East Hall 3 /3H30

More information about CPhI Japan: http://www.cphijapan.com/